The transaction materially strengthens Aclarion’s balance sheet, preserves capital structure integrity, and significantly ...

Chronic rhinosinusitis (CRS) significantly affects ophthalmologic health but remains largely manageable, according to a ...

Medical-technology startup Aclarion Inc. (Nasdaq: ACON) recently raised $10.4 million in capital through a stock offering.

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers ...

Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S. spine centers have now completed the regulatory and ...

Utah’s AI prescribing program tries to solve a legitimate problem, but eliminating the doctor from certain clinical decisions ...

Quarterly Nociscan scan volumes increased 114% year-over-year in Q4 2025Annual Nociscan scan volumes increased 69% ...

Monash researchers will share in $53.3 million across a total of 32 awards, as a part of the National Health and Medical ...

Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...